Article Versions Notes

Couse Z, Cui X, Li Y, Moayeri M, Leppla S, Eichacker PQ. A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models. Toxins. 2021; 13(1):53. https://doi.org/10.3390/toxins13010053

Couse, Zoe, Xizhong Cui, Yan Li, Mahtab Moayeri, Stephen Leppla, and Peter Q. Eichacker. 2021. "A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models" Toxins 13, no. 1: 53. https://doi.org/10.3390/toxins13010053

Couse, Z., Cui, X., Li, Y., Moayeri, M., Leppla, S., & Eichacker, P. Q. (2021). A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models. Toxins, 13(1), 53. https://doi.org/10.3390/toxins13010053